Global Drug Facility
The Global Drug Facility (GDF) is an initiative to increase access to high quality tuberculosis (TB) drugs for DOTS implementation, a TB control strategy. Globally, TB is the leading curable cause of death from infectious disease. The GDF is housed in WHO headquarters in Geneva and managed by a small team in the Stop TB Partnership Secretariat.
December 2011 - GDF and The Global Fund invite manufacturers of first, second and third-line anti-tuberculosis medicines to submit an Expression of Interest (EoI) for product evaluation by Expert Review Panel (ERP)
The deadline for submission is 28 February 2012, 17:00 h Geneva time.
28 November 2011 - Announcing the twenty-sixth round of applications for Global Drug Facility grants
28 November 2011 - Lancement du 26eme appel a candidatures pour des subventions du service pharmaceutique mondial
28 November 2011 - Anuncio se la ronda 26 de solicitudes para la obtencion de subvenciones del servicio farmaceutico mundial
July 2011 - GDF and The Global Fund invite manufacturers of first, second and third-line anti-tuberculosis medicines to submit an Expression of Interest (EoI) for product evaluation by Expert Review Panel (ERP)
The deadline for submission is 15 September 2011, 17:00 h Geneva time.
22 November 2010 - Global Drug Facility releases roadmap for scale-up of MDR-TB treatment
In This Section
GDF is ISO 9001:2000 compliant for provision of quality-assured anti-TB drugs and related services to eligible national TB control programmes.